Harmine Hydrochloride Induces G2/M Cell Cycle Arrest and Apoptosis in SK-Hep1 Hepatocellular Carcinoma Cells by Regulating Mitogen-Activated Protein Kinases and the PI3K/AKT Pathway

Overview

Journal Prev Nutr Food Sci

Date 2024 Jan 8

PMID 38188092

Authors

Gi Dae Kim

Affiliations

Soon will be listed here.

Abstract

Liver cancer is a globally common form of cancer. Thus, novel drugs derived from natural products are needed to reduce the side effects of chemotherapy. The present study aimed to analyze the anticancer properties and effects of harmine hydrochloride (HMH), a water-soluble metabolite of harmine that can be easily absorbed into tissues, in treating liver cancer cells. HMH dose-dependently inhibited cell growth, migration, invasion, and colony formation in SK-Hep1 cells. It also induced G2/M arrest by reducing the expression of p-cdc2, cyclin B1, and Rb (G2/M phase regulatory proteins) in a dose-dependent manner. HMH treatment reduced the expression of caspase-9, caspase-3, PARP, and Bcl-2 and increased the expression of Bax (a proapoptotic protein). Moreover, it increased the production of reactive oxygen species and decreased the intracellular uptake of rhodamine 123 due to mitochondrial dysfunction because of oxidative stress. HMH treatment also upregulated the phosphorylation of JNK, p38, and FOXO3a in SK-Hep1 cells and downregulated the PI3K/AKT signaling pathway. Our findings suggest that HMH may activate the compounds responsible for anticancer effects in hepatocellular carcinoma cells.

Citing Articles

Knockdown of CCNB2 inhibits the tumorigenesis of gastric cancer by regulation of the PI3K/Akt pathway.

Hu M, Tao P, Wang Y, Zhu C, Ma Y, Liu X Sci Rep. 2025; 15(1):5703.

PMID: 39962178 PMC: 11832750. DOI: 10.1038/s41598-025-89948-4.

References

Chae W, Kim G . Dioscin Decreases Breast Cancer Stem-like Cell Proliferation via Cell Cycle Arrest by Modulating p38 Mitogen-activated Protein Kinase and AKT/mTOR Signaling Pathways. J Cancer Prev. 2021; 26(3):183-194. PMC: 8511578. DOI: 10.15430/JCP.2021.26.3.183. View

Zhou F, Yang Y, Xing D . Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J. 2010; 278(3):403-13. DOI: 10.1111/j.1742-4658.2010.07965.x. View

Sanchez I, Dynlacht B . New insights into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol. 2005; 16(3):311-21. DOI: 10.1016/j.semcdb.2005.02.007. View

Kim G, Oh J, Park H, Bae K, Lee S . Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells. Int J Oncol. 2013; 43(2):600-10. DOI: 10.3892/ijo.2013.1959. View

Chen Z, Li J, Zhu S, Li Z, Yu J, Wu J . Harmine reinforces the effects of regorafenib on suppressing cell proliferation and inducing apoptosis in liver cancer cells. Exp Ther Med. 2022; 23(3):209. PMC: 8796640. DOI: 10.3892/etm.2022.11132. View

Li S, Wang A, Gu F, Wang Z, Tian C, Qian Z . Novel harmine derivatives for tumor targeted therapy. Oncotarget. 2015; 6(11):8988-9001. PMC: 4496197. DOI: 10.18632/oncotarget.3276. View

Sunters A, Fernandez de Mattos S, Stahl M, Brosens J, Zoumpoulidou G, Saunders C . FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem. 2003; 278(50):49795-805. DOI: 10.1074/jbc.M309523200. View

Zhang H, Sun K, Ding J, Xu H, Zhu L, Zhang K . Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer. Phytomedicine. 2013; 21(3):348-55. DOI: 10.1016/j.phymed.2013.09.007. View

Brancho D, Ventura J, Jaeschke A, Doran B, Flavell R, Davis R . Role of MLK3 in the regulation of mitogen-activated protein kinase signaling cascades. Mol Cell Biol. 2005; 25(9):3670-81. PMC: 1084312. DOI: 10.1128/MCB.25.9.3670-3681.2005. View

10.

Zhang J, Yu X, Yan Y, Wang C, Wang W . PI3K/Akt signaling in osteosarcoma. Clin Chim Acta. 2015; 444:182-92. DOI: 10.1016/j.cca.2014.12.041. View

11.

Taniguchi K, Ii H, Kageyama S, Takagi H, Chano T, Kawauchi A . Depletion of gamma-glutamylcyclotransferase inhibits cancer cell growth by activating the AMPK-FOXO3a-p21 axis. Biochem Biophys Res Commun. 2019; 517(2):238-243. DOI: 10.1016/j.bbrc.2019.07.049. View

12.

Simon H, Levi-Schaffer F . Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2001; 5(5):415-8. DOI: 10.1023/a:1009616228304. View

13.

Khan K, Blanco-Codesido M, Molife L . Cancer therapeutics: Targeting the apoptotic pathway. Crit Rev Oncol Hematol. 2014; 90(3):200-19. DOI: 10.1016/j.critrevonc.2013.12.012. View

14.

Chen X, Dai X, Zou P, Chen W, Rajamanickam V, Feng C . Curcuminoid EF24 enhances the anti-tumour activity of Akt inhibitor MK-2206 through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in gastric cancer. Br J Pharmacol. 2017; 174(10):1131-1146. PMC: 5406301. DOI: 10.1111/bph.13765. View

15.

Gogvadze V, Orrenius S, Zhivotovsky B . Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol. 2008; 19(1):57-66. DOI: 10.1016/j.semcancer.2008.11.007. View

16.

Smith H, Southgate H, Tweddle D, Curtin N . DNA damage checkpoint kinases in cancer. Expert Rev Mol Med. 2020; 22:e2. DOI: 10.1017/erm.2020.3. View

17.

Ock C, Kim G . Harmine Hydrochloride Mediates the Induction of G2/M Cell Cycle Arrest in Breast Cancer Cells by Regulating the MAPKs and AKT/FOXO3a Signaling Pathways. Molecules. 2021; 26(21). PMC: 8588485. DOI: 10.3390/molecules26216714. View

18.

Tan B, Li Y, Zhao Q, Fan L, Zhang M . The impact of Harmine hydrochloride on growth, apoptosis and migration, invasion of gastric cancer cells. Pathol Res Pract. 2020; 216(8):152995. DOI: 10.1016/j.prp.2020.152995. View

19.

Chau G, Lui W, Tsay S, Chao Y, King K, Wu C . Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study. Ann Surg Oncol. 2006; 13(10):1329-37. DOI: 10.1245/s10434-006-9004-1. View

20.

Calderaro J, Ziol M, Paradis V, Zucman-Rossi J . Molecular and histological correlations in liver cancer. J Hepatol. 2019; 71(3):616-630. DOI: 10.1016/j.jhep.2019.06.001. View